CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 15, 2023 · earnings

FDMT earnings: a negative outcome, -6.1%

On March 15, 2023, 4D Molecular Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.1% in the window around the event. It had already run -22.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$18.49
1d before
$17.37
Event day
$18.36
1d after
$17.50
5d after

Pre-catalyst setup

-22.0%
30-day run-up
9246%
30-day volatility
1.3×
volume spike